Study Summary
This trial will test new sequences on patients and healthy volunteers.
Treatment Effectiveness
Effectiveness Progress
This is further along than 93% of similar trials
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 5 years
5 years
Conduct clinical protocol development and validation
Demonstrate and train
Trial Safety
Safety Progress
This is further along than 85% of similar trials
Trial Design
0 Treatment Group
2000 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,448 Previous Clinical Trials
773,899 Total Patients Enrolled
Eligibility Criteria
Age 18 - 90 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:• Age at least 18 years.
You have a GFR ≥30 ml/min.
When contrast is being administered: healthy volunteers with a GFR≥60 ml/min.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments